News & Trends - Pharmaceuticals

$3 million medicinal cannabis research to benefit cancer patients

Health Industry Hub | October 9, 2019 |
[Total: 1    Average: 5/5]

The Morrison Government is investing $3 million from the Medical Research Future Fund (MRFF) to examine the benefits of medicinal cannabis for pain, symptom and side effect management for cancer patients.

Since her own battle, Ms Olivia Newton-John has been an advocate for breast cancer awareness and research, and through her personal experience and ongoing efforts has helped shine a light on the benefits associated with medicinal cannabis. 

Overall more than 11,000 patients are estimated to have been approved to access medicinal cannabis products – with the majority approved this year.

There have only been a limited number of well-designed clinical studies on medicinal cannabis, and there is a need to increase the evidence base to support medical professionals to make their decisions.

Given the increase in prescribed medicinal cannabis, the Government has supported the nation’s medicinal cannabis industry, and cut red tape, to help meet demand.

Fully connected organisations are 52% more valuable. How are you moving beyond the transactional touchpoints?
Differentiate your offering and amplify your brand value proposition to our 8,500+ industry professionals. Health Industry Hub offers a wealth of content in the only one-stop-hub to connect and engage Pharma, MedTech and Biotech industry professionals. Ask us how.

The medicinal cannabis industry has the potential to make a significant contribution to exports, employment and economic growth, particularly in rural and regional areas.

The first licence for an Australian company to grow and harvest medicinal cannabis was granted in March 2017, and we’re now up to 78 licences.

To support further growth in the industry, applicants with Major Project Status will be given priority to receive medicinal cannabis licences through the Office of Drug Control.

Medical research is one of the core elements of the Morrison Government’s $104 billion Long Term National Health Plan.

You may also like PSA strengthens support for Australian pharmacists working in general practice


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - Pharma industry pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

Pharma industry pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

Health Industry Hub | June 5, 2020 |

The world’s leading biopharmaceutical and vaccines companies restate their commitment to supporting the Vaccine Alliance Gavi‘s mission to protect future […]

More


Leadership & Management

Leadership Management Qualities - Resuming face to face interactions with healthcare professionals post COVID-19

Resuming face to face interactions with healthcare professionals post COVID-19

Health Industry Hub | June 4, 2020 |

As countries lift lockdown restrictions, the international pharma industry body, IFPMA, provides its members with ethical considerations on when and how to […]

More


News & Trends - Medical Technology

MedTech News - Varian's AI machine personalises cancer therapy and halves treatment time

Varian’s AI machine personalises cancer therapy and halves treatment time

Health Industry Hub | June 3, 2020 |

MedTech News: A Sydney patient is the first Australian in the Southern Hemisphere to receive revolutionary new personalised cancer therapy […]

More


News & Trends - Pharmaceuticals

Pharma News - ASCO highlights - Janssen, Takeda, AZ, Genentech, MSD, BMS and Noxopharm

ASCO highlights – Janssen, Takeda, AZ, Genentech, MSD, BMS and Noxopharm

Health Industry Hub | June 3, 2020 |

Pharma News: The American Society of Clinical Oncology (ASCO) 2020 meeting was held virtually this year due to the COVID-19 […]

More